Q: I believe that the traditional "weight loss advisory" firms will recover especially once some of the attendant health risks from such drugs as Ozempic become better known. Does this theory resonate with you and, if so, which Weight Watcher-type firms do you like?
Best regards,
David

Q: Good morning Ryan, Peter, and 5i Team,

Given the recent earnings miss and resulting downward momentum of WW shares, are you still confident that the thesis for investing in Medifast holds water? If not, might you suggest which one of your favourite US growth stocks (any sector) that you might currently prefer over Medifast? Thanks for your great service!

Brad

Q: Jean Francois tardif chose this one as a top reopening contender to benefit from the reopening trade. It hasn’t panned out. Do you like the company? Would you keep holding ? Thank you